Skip to main content
. Author manuscript; available in PMC: 2023 Feb 4.
Published in final edited form as: N Engl J Med. 2022 Aug 4;387(5):397–407. doi: 10.1056/NEJMoa2203067

Figure 3. Serum Concentrations of L9LS.

Figure 3.

Panel A shows the geometric mean serum concentrations of L9LS with 95% confidence intervals (indicated by I bars) for each dose group after administration of a single dose of L9LS. Panel B shows the serum concentrations of L9LS over time in individual trial participants who underwent CHMI. Individual horizontal dotted lines with open circles indicate malaria infection (in one participant who received 1 mg per kilogram intravenously and in one participant who received 5 mg per kilogram subcutaneously).